«Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway». Nigerian Journal of Physiological Sciences, vol. 40, núm. 2, abril 2026, https://doi.org/10.54548/.